Success Metrics

Clinical Success Rate
76.9%

Based on 10 completed trials

Completion Rate
77%(10/13)
Active Trials
0(0%)
Results Posted
60%(6 trials)
Terminated
3(23%)

Phase Distribution

Ph not_applicable
2
15%
Ph early_phase_1
1
8%
Ph phase_3
2
15%
Ph phase_1
2
15%
Ph phase_4
3
23%
Ph phase_2
3
23%

Phase Distribution

3

Early Stage

3

Mid Stage

5

Late Stage

Phase Distribution13 total trials
Early Phase 1First-in-human
1(7.7%)
Phase 1Safety & dosage
2(15.4%)
Phase 2Efficacy & side effects
3(23.1%)
Phase 3Large-scale testing
2(15.4%)
Phase 4Post-market surveillance
3(23.1%)
N/ANon-phased studies
2(15.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

76.9%

10 of 13 finished

Non-Completion Rate

23.1%

3 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(10)
Terminated(3)

Detailed Status

Completed10
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
76.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (7.7%)
Phase 12 (15.4%)
Phase 23 (23.1%)
Phase 32 (15.4%)
Phase 43 (23.1%)
N/A2 (15.4%)

Trials by Status

terminated323%
completed1077%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials
NCT04526210Phase 1

Study of ALXN1840 on the Metabolism of a CYP2B6 Substrate in Healthy Participants

Completed
NCT03326128Phase 2

High Dose Bupropion for Smoking Cessation - Pilot Study

Terminated
NCT02582008Early Phase 1

Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

Terminated
NCT00135512Phase 2

Study Of 323U66 SR In Major Depressive Disorder

Completed
NCT02744417Not Applicable

Effect of Smoking Cessation on Clinical and Microbiological Outcomes of the Non-surgical Periodontal Therapy

Completed
NCT00666978Phase 4

Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking

Completed
NCT00534001Phase 2

Bupropion in Helping Adults Stop Smoking

Completed
NCT01574703Phase 4

Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders.

Completed
NCT00033592Phase 3

Comparison of Nicotine Inhaler and/or Bupropion in Helping People to Stop Smoking and Prevent the Recurrence of Smoking

Completed
NCT01456936Phase 4

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders

Completed
NCT01635972Phase 1

Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion

Completed
NCT00032084Phase 3

S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery

Terminated
NCT00079469Not Applicable

Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who Continue to Smoke

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13